Article info

Download PDFPDF

Restriction of LABA use to combination ICS/LABA inhaler therapy in asthma

Authors

  • Richard Beasley Department of Internal Medicine, Medical Research Institute of New Zealand, Wellington, New ZealandDepartment of Internal Medicine, Capital & Coast District Health Board, Wellington, New Zealand PubMed articlesGoogle scholar articles
  • James Fingleton Department of Internal Medicine, Medical Research Institute of New Zealand, Wellington, New ZealandDepartment of Internal Medicine, Capital & Coast District Health Board, Wellington, New Zealand PubMed articlesGoogle scholar articles
  • Mark Weatherall Department of Internal Medicine, Capital & Coast District Health Board, Wellington, New ZealandDepartment of Medicine, University of Otago Wellington, Wellington, New Zealand PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Richard Beasley, Medical Research Institute of New Zealand, Private Bag 7902, Wellington 6242, New Zealand; Richard.Beasley{at}mrinz.ac.nz
View Full Text

Citation

Beasley R, Fingleton J, Weatherall M
Restriction of LABA use to combination ICS/LABA inhaler therapy in asthma

Publication history

  • Received August 21, 2012
  • Revised September 23, 2012
  • Accepted October 18, 2012
  • First published November 13, 2012.
Online issue publication 
January 15, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.